Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.14%
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.40 times
2
The company has declared negative results in Dec'2023 after 2 consecutive positive quarters
3
With ROE of 5.64%, it has a Very Expensive valuation with a 1.70 Price to Book Value
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.26%
0%
-0.26%
6 Months
-13.91%
0%
-13.91%
1 Year
-18.36%
0%
-18.36%
2 Years
-2.01%
0%
-2.01%
3 Years
-4.87%
0%
-4.87%
4 Years
-19.0%
0%
-19.0%
5 Years
9.92%
0%
9.92%
Alcon AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.77%
EBIT Growth (5y)
42.14%
EBIT to Interest (avg)
6.34
Debt to EBITDA (avg)
1.40
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.36
Tax Ratio
15.88%
Dividend Payout Ratio
15.44%
Pledged Shares
0
Institutional Holding
59.58%
ROCE (avg)
4.14%
ROE (avg)
3.73%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
1.70
EV to EBIT
25.23
EV to EBITDA
13.74
EV to Capital Employed
1.61
EV to Sales
3.76
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
6.37%
ROE (Latest)
5.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 9 Schemes (2.64%)
Foreign Institutions
Held by 1141 Foreign Institutions (45.29%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,144.20
2,223.20
-3.55%
Operating Profit (PBDIT) excl Other Income
497.20
711.10
-30.08%
Interest
42.10
44.00
-4.32%
Exceptional Items
-57.80
-11.70
-394.02%
Consolidate Net Profit
145.40
314.60
-53.78%
Operating Profit Margin (Excl OI)
109.00%
194.50%
-8.55%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -3.55% vs 1.27% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -53.78% vs 26.24% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
8,728.30
8,496.80
2.72%
Operating Profit (PBDIT) excl Other Income
2,329.40
2,158.60
7.91%
Interest
169.10
169.80
-0.41%
Exceptional Items
-3.50
-127.60
97.26%
Consolidate Net Profit
896.50
875.30
2.42%
Operating Profit Margin (Excl OI)
143.00%
124.90%
1.81%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.72% vs 2.06% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 2.42% vs 173.62% in Dec 2023
About Alcon AG 
Alcon AG
Pharmaceuticals & Biotechnology
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.
Company Coordinates 
Company Details
Rue Louis-d'Affry 6 , FRIBOURG None : 1701
Registrar Details






